Wow!
Did Mark just confirm that Prof. Voit is going to be our “PI” for the EMA trial?
i.e. Principle Investigator
If so, then get ready for one big trial covering EMA and FDA programs....that will include combination therapy arm with Sarepta.
The Professor was very excited by the P2 results in his video interview with Shane Storey.
He also owns the ‘microdystrophin’ IP Sarepta are using.
Win win.
ANP presenting now, page-41
-
- There are more pages in this discussion • 143 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $94.66M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 9.8¢ | $58.09K | 574.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 38503 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 194063 | 5 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |